An Essential Role of the CAAT/Enhancer Binding Protein-α in the Vitamin D-Induced Expression of the Human Steroid/Bile Acid-Sulfotransferase (SULT2A1)
-
- Chung S. Song
- Department of Molecular Medicine/Institute of Biotechnology (C.S.S., I.E., Y.-K.S., T.O., S.K., S.-A.K., S.C., L.S., B.C.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245;
-
- Ibtissam Echchgadda
- Department of Molecular Medicine/Institute of Biotechnology (C.S.S., I.E., Y.-K.S., T.O., S.K., S.-A.K., S.C., L.S., B.C.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245;
-
- Young-Kyo Seo
- Department of Molecular Medicine/Institute of Biotechnology (C.S.S., I.E., Y.-K.S., T.O., S.K., S.-A.K., S.C., L.S., B.C.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245;
-
- Taesung Oh
- Department of Molecular Medicine/Institute of Biotechnology (C.S.S., I.E., Y.-K.S., T.O., S.K., S.-A.K., S.C., L.S., B.C.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245;
-
- Soyoung Kim
- South Texas Veterans Health Care System (S.K., S.C., B.C.), Audie L. Murphy Veterans Affairs Hospital, San Antonio, Texas 78229
-
- Sung-A Kim
- Department of Molecular Medicine/Institute of Biotechnology (C.S.S., I.E., Y.-K.S., T.O., S.K., S.-A.K., S.C., L.S., B.C.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245;
-
- Sunghwan Cho
- Department of Molecular Medicine/Institute of Biotechnology (C.S.S., I.E., Y.-K.S., T.O., S.K., S.-A.K., S.C., L.S., B.C.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245;
-
- Liheng Shi
- Department of Molecular Medicine/Institute of Biotechnology (C.S.S., I.E., Y.-K.S., T.O., S.K., S.-A.K., S.C., L.S., B.C.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245;
-
- Bandana Chatterjee
- Department of Molecular Medicine/Institute of Biotechnology (C.S.S., I.E., Y.-K.S., T.O., S.K., S.-A.K., S.C., L.S., B.C.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245;
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>The vitamin D receptor (VDR) regulates steroid and drug metabolism by inducing the genes encoding phase I and phase II enzymes. SULT2A1 is a liver- and intestine-expressed sulfo-conjugating enzyme that converts the alcohol-OH of neutral steroids, bile acids, and drugs to water-soluble sulfated metabolites. 1α,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] induces SULT2A1 gene transcription after the recruitment of VDR to the vitamin D-responsive chromatin region of SULT2A1. A composite element in human SULT2A1 directs the 1,25-(OH)2D3-mediated induction of natural and heterologous promoters. This element combines a VDR/retinoid X receptor-α-binding site [vitamin D response element (VDRE)], which is an imperfect inverted repeat 2 of AGCTCA, and a CAAT/enhancer binding protein (C/EBP)-binding site located 9 bp downstream to VDRE. The binding sites were identified by EMSA, antibody supershift, and deoxyribonuclease I footprinting. C/EBP-α at the composite element plays an essential role in the VDR regulation of SULT2A1, because 1) induction was lost for promoters with inactivating mutations at the VDRE or C/EBP element; 2) SULT2A1 induction by 1,25-(OH)2D3 in C/EBP-α-deficient cells required the expression of cotransfected C/EBP-α; and 3) C/EBP-β did not substitute for C/EBP-α in this regulation. VDR and C/EBP-α were recruited concurrently to the composite element along with the coactivators p300, steroid receptor coactivator 1 (SRC-1), and SRC-2, but not SRC-3. VDR and C/EBP-α associated endogenously as a DNA-dependent, coimmunoprecipitable complex, which was detected at a markedly higher level in 1,25-(OH)2D3-treated cells. These results provide the first example of the essential role of the interaction in cis between C/EBP-α and VDR in directing 1,25-(OH)2D3-induced expression of a VDR target gene.</jats:p>
収録刊行物
-
- Molecular Endocrinology
-
Molecular Endocrinology 20 (4), 795-808, 2006-04-01
The Endocrine Society